iifl-logo

Suven Pharmaceuticals Ltd Share Price Live

922.9
(2.62%)
Sep 5, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open906
  • Day's High926
  • 52 Wk High1,360
  • Prev. Close899.3
  • Day's Low897.5
  • 52 Wk Low 856.3
  • Turnover (lac)771.04
  • P/E97.52
  • Face Value1
  • Book Value62.24
  • EPS9.23
  • Mkt. Cap (Cr.)35,307.12
  • Div. Yield0
View All Historical Data

No Record Found

Loading...

Suven Pharmaceuticals Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

906

Prev. Close

899.3

Turnover(Lac.)

771.04

Day's High

926

Day's Low

897.5

52 Week's High

1,360

52 Week's Low

856.3

Book Value

62.24

Face Value

1

Mkt Cap (₹ Cr.)

35,307.12

P/E

97.52

EPS

9.23

Divi. Yield

0

Suven Pharmaceuticals Ltd Corporate Action

13 Jul 2024

12:00 AM

AGM

Announcement Date: 13 Jul, 2024

arrow

29 Oct 2024

12:00 AM

EGM

arrow

27 Jun 2025

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

12 Jul 2024

12:00 AM

BookCloser

arrow

Cohance Lifesciences Ltd NEWS AND UPDATE

Suven Pharma Q3 Profit Jumps 77% YoY, Revenue Up 40%

Revenue from operations of the company stood at ₹307.2 crore, with a Year-on-Year (YoY) growth of 39.8% quarter over Q3 FY24 as compared to ₹219.8 crore

13 Feb 2025|03:10 PM
Read More
Suven Pharma picks up controlling stake in NJ Bio for ₹535 Crore

Suven is now a prominent player in the ADC outsourcing market, estimated to be worth $2.7 billion (approx. ₹22,815 Crore).

9 Dec 2024|07:23 AM
Read More
Top 10 stocks for today – 12th August 2024

Here are some of the stocks that may see significant price movement today: Adani Enterprises, Siemens, Aurobindo Pharma, etc.

12 Aug 2024|08:48 AM
Read More
Top 10 stocks for today – 15th July, 2024

Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.

15 Jul 2024|08:59 AM
Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Cohance Lifesciences Ltd SHAREHOLDING SNAPSHOT

05 Sep, 2025|11:17 PM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 66.41%

Foreign: 66.41%

Indian: 0.00%

Non-Promoter- 18.63%

Institutions: 18.63%

Non-Institutions: 14.94%

Custodian: 0.00%

Share Price

Suven Pharmaceuticals Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Y/e 31 Mar( In .Cr)Mar-2025Mar-2024Mar-2023Mar-2022

Equity Capital

25.46

25.46

25.46

25.46

Preference Capital

0

0

0

0

Reserves

2,290.09

2,002.89

1,723.92

1,495.24

Net Worth

2,315.55

2,028.35

1,749.38

1,520.7

Minority Interest

View Balance Sheet
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Revenue

1,320.22

1,009.71

833.78

0

yoy growth (%)

30.75

21.09

0

Raw materials

-399.1

-301.94

-229.18

0

As % of sales

30.23

29.9

27.48

0

Employee costs

-100.48

-76.23

-73.72

0

View Profit & Loss
Y/e 31 Mar( In .Cr)Mar-2022Mar-2021Mar-2020Mar-2019

Profit before tax

722.44

413.97

357.59

-0.02

Depreciation

-39.09

-31.63

-23.86

0

Tax paid

-164.34

-105.33

-87.51

0

Working capital

215.89

16.14

-52.93

Other operating items

View Cash Flow

No Record Found

Particulars (Rupees in Crores.)Mar-2025Mar-2024Mar-2023Mar-2022Mar-2021

Gross Sales

2,608.5

1,051.35

1,340.33

1,320.22

1,009.72

Excise Duty

0

0

0

0

0

Net Sales

2,608.5

1,051.35

1,340.33

1,320.22

1,009.72

Other Operating Income

0

0

0

0

0

Other Income

69.21

61.91

46.36

133.49

67.97

Suven Pharmaceuticals Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceutical Industries Ltd

SUNPHARMA

1,582.3

76.223,79,658.77753.531.015,566.68101.44

Divis Laboratories Ltd

DIVISLAB

6,133.5

69.731,62,886.215570.492,357561.08

Cipla Ltd

CIPLA

1,577.8

24.671,27,435.321,303.131.014,501.66397.38

Torrent Pharmaceuticals Ltd

TORNTPHARM

3,599.3

61.231,21,713.055510.172,567224.34

Mankind Pharma Ltd

MANKIND

2,568.9

58.531,05,917.96412.7602,541.36354.69

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Suven Pharmaceuticals Ltd

Management

Register Office

Registrar Office

Non Executive Director

Shweta Jalan

Independent Director

U B Pravin Rao

Managing Director

Venkatanaga Kali Vara Prasad Raju Vetukuri

Non Executive Director

Pankaj Patwari

Independent Director

Matangi Gowrishankar

Independent Director

Vinod Rao

Independent Director

K G Ananthakrishnan

Executive Chairman & Director

VIVEK SHARMA

Company Sec. & Compli. Officer

Kundan Kumar Jha

Additional Director

Jaishankar Krishnan

Additional Director

Vinod Padikkal

Registered Office

8-2-334 SDE Serene Chambers,

3 Floor Avenue 7 Road No 5,

Telangana - 500034

Tel: 91-40-23549414/1142/3311

Website: http://www.suvenpharm.com

Email: khrao@suvenpharm.com

Registrar Office

Karvy Selenium Tow-B,

31&32 Financial Dist, Nanakramguda,

Hyderabad-500032

Tel: 91-40-67162222

Website: www.kfintech.com

Email: einward.ris@kfintech.com

Summary

Cohance Lifesciences Limited, formerly known as Suven Pharmaceuticals Limited was incorporated on November 6, 2018. The name of the Company has been changed to Cohance Lifesciences Limited w.e.f. May ...
Read More

Company FAQs

What is the Cohance Lifesciences Ltd share price today?

The Cohance Lifesciences Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹922.9 today.

What is the Market Cap of Cohance Lifesciences Ltd?

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Cohance Lifesciences Ltd is ₹35307.12 Cr. as of 05 Sep ‘25

What is the PE and PB ratio of Cohance Lifesciences Ltd?

The PE and PB ratios of Cohance Lifesciences Ltd is 97.52 and 14.79 as of 05 Sep ‘25

What is the 52 Week High and Low of Cohance Lifesciences Ltd?

The 52-week high/low is the highest and lowest price at which a Cohance Lifesciences Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Cohance Lifesciences Ltd is ₹856.3 and ₹1360 as of 05 Sep ‘25

What is the CAGR of Cohance Lifesciences Ltd?

Cohance Lifesciences Ltd's CAGR for 5 Years at 22.05%, 3 Years at 22.16%, 1 Year at -20.32%, 6 Month at -22.71%, 3 Month at -11.99% and 1 Month at -6.18%.

What is the shareholding pattern of Cohance Lifesciences Ltd?

The shareholding pattern of Cohance Lifesciences Ltd is as follows:
Promoters - 66.41 %
Institutions - 18.64 %
Public - 14.95 %
Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.